G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995-Backstory of BCS

AAPS Journal

Volumn 16, Issue 5, 2014, Pages 894-898

  Shah, Vinod P ^a   Amidon, Gordon L ^b  

^a College of Pharmacy University of Michigan ^*

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

absorption; biopharmaceutics; dissolution standards; intestinal permeability; solubility

Indexed keywords

DRUG;

BIOEQUIVALENCE; CORRELATIONAL STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLASSIFICATION; DRUG DISPOSITION; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE PERMEABILITY; NARROW THERAPEUTIC INDEX; NONHUMAN; NOTE; PH; PHARMACOLOGICAL PARAMETERS; THEORY; WORLD HEALTH ORGANIZATION; ANIMAL; BIOAVAILABILITY; BIOLOGICAL MODEL; CHEMICAL MODEL; CHEMISTRY; CLASSIFICATION; DRUG ADMINISTRATION ROUTE; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HISTORY; METABOLISM; NOMENCLATURE; PHARMACEUTICS; PHARMACOKINETICS; SOLUBILITY; UNITED STATES;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOPHARMACEUTICS; DRUG ADMINISTRATION ROUTES; DRUG APPROVAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLUBILITY; TERMINOLOGY AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84908357128     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-014-9620-9     Document Type: Note

References (20)

1. Amidon GL et al. Analysis of models for determining intestinal wall permeabilities. J Pharm Sci. 1980;69(12):1369-73. (Pubitemid 11172811)
2. Amidon GL, Sinko PJ, Fleisher D. Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res. 1988;5(10):651-4. (Pubitemid 18263612)
3. Oh DM, Curl RL, Amidon GL. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm Res. 1993;10(2):264-70. (Pubitemid 23041742)
4. Elliott RL, Amidon GL, Lightfoot EN. A convective mass transfer model for determining intestinal wall permeabilities: laminar flow in a circular tube. J Theor Biol. 1980;87(4):757-71. (Pubitemid 11170931)
5. Sinko PJ, Leesman GD, Amidon GL. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm Res. 1991;8(8):979-88.
6. Knutson L et al. Segmental intestinal perfusion. A "new" technique for human studies. Lakartidningen. 1994;91(19):1941-6.
7. Lennernas H et al. The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br J Clin Pharmacol. 1993;35(3):243-50. (Pubitemid 23074047)
8. Lennernas H et al. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm Res. 1992;9(10):1243-51.
9. Dressman JB, Amidon GL, Fleisher D. Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci. 1985;74(5):588-9.
10. Amidon GL et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20.
11. CDER/FDA, U.S. Department of Health and Human Services Food and Drug Administration Center for Evaluation and Research (CDER). In: Guidances for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. 2000.
12. Vidon N et al. Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol. 1985;19 Suppl 2:107S-12S. (Pubitemid 16193629)
13. Jobin G et al. Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol. 1985;19 Suppl 2:97S-105S. (Pubitemid 16193628)
14. Jobin G et al. Investigation of drug absorption from the gastrointestinal tract of man. V. Effect of the beta-adrenoceptor antagonist, metoprolol, on postprandial gastric function. Br J Clin Pharmacol. 1985;19 Suppl 2:127S-35S. (Pubitemid 16193632)
15. Hirtz J. The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol. 1985;19 Suppl 2:77S-83S. (Pubitemid 16193625)
16. Godbillon J et al. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol. 1985;19 Suppl 2:113S-8S. (Pubitemid 16193630)
17. WHO. WHO Technical report series 937, Annex 7 Multisource (generic) pharmaceutical products. Guidance on registration requirements to establish interchangeability. Geneva, Switzerland; 2006.
18. Kasim NA et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 2004;1(1):85-96.
19. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005;22(1):11-23. (Pubitemid 40558141)
20. Tsume Y, et al. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 2014.